Skip to content

Sagimet Biosciences

US · SGMT #3599 by market cap Listed 2023
8.88 +0.12 +1.37%
Live - 5344 symbols - heartbeat 24s ago · 2026-10-08 09:10
Pre-market 8.96 +0.90%
After-hours 8.88 0.00%
Market cap
629.67M
P/B
2.46
EPS
-1.58
Reader sentiment Are you bullish or bearish on SGMT?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 12 analysts

Buy
Avg price target 28.46 +220.5%
Price target rangecurrent 8.88
Low7.00
Avg28.46
High56.00
Buy 92% Hold 0% Sell 8%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-05 H.C. Wainwright -- BUY 29.00
2026-10-01 Cantor Fitzgerald -- BUY 25.10
2026-10-01 CCORF -- BUY 56.00
2026-10-01 Wedbush -- BUY 28.00
2026-10-01 Citizens JMP -- BUY 27.00
2026-10-01 Guggenheim -- BUY 26.00
2026-10-01 Leerink Partners -- BUY --
2026-10-01 Oppenheimer -- BUY 38.00
2026-09-30 Clear Street -- BUY 28.00
2026-09-30 Goldman Sachs -- SELL 7.00
2026-09-27 JonesTrading -- BUY 31.00
2026-09-25 H.C. Wainwright -- BUY 29.00
2026-09-24 Goldman Sachs -- SELL 7.00
2026-09-21 H.C. Wainwright -- BUY 29.00
2026-09-09 Cantor Fitzgerald -- BUY 26.00
2026-09-09 Barclays -- BUY 18.00
2026-08-26 H.C. Wainwright -- BUY 29.00
2026-08-25 JonesTrading -- BUY 31.00
2026-08-25 H.C. Wainwright -- BUY 29.00
2026-08-12 Guggenheim -- BUY 25.00
2026-08-12 Oppenheimer -- BUY 33.00
2026-08-11 CCORF -- BUY 56.00
2026-08-11 Wedbush -- BUY 28.00
2026-08-11 H.C. Wainwright -- BUY 29.00
2026-07-21 JonesTrading -- BUY 31.00

Price target trend monthly average, last 3 years

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Barclays moved from Hold to Buy on 2026-09-09.

Recent rating changes

DateFirmChangeTarget
2026-09-09 Barclays HOLD → BUY 18.00

Quote time 2026-10-08 09:10:25 · For reference only, not investment advice and not tailored to your situation.